This is a StreetInsider.com Premium Only Page

Eli Lilly & Co. (LLY) – Major News

Feb 6, 2024 06:47 AM Eli Lilly & Co. (LLY) Tops Q4 EPS by 18c; offers guidance

Nov 2, 2023 06:31 AM Eli Lilly & Co. (LLY) Tops Q3 EPS by 30c; Trims Outlook

Oct 3, 2023 06:45 AM Eli Lilly & Co. (LLY) to Acquire POINT Biopharma (PNT) for $12.50/sh Cash or $1.4B

Aug 8, 2023 06:49 AM Eli Lilly & Co. (LLY) Tops Q2 EPS by 13c; raises guidance

Jun 29, 2023 06:46 AM Eli Lilly & Co. (LLY) to Acquire Sigilon Therapeutics (SGTX) for $14.92/sh plus CVR

Jun 20, 2023 06:45 AM Eli Lilly & Co. (LLY) to Acquire DICE Therapeutics (DICE) for $48/sh or $2.4B

Apr 27, 2023 06:47 AM Eli Lilly & Co. (LLY) Misses Q1 EPS by 7c; Guides Raised

Feb 2, 2023 06:57 AM Eli Lilly & Co. (LLY) Tops Q4 EPS by 29c, Lifts Outlook

Nov 1, 2022 06:27 AM Eli Lilly & Co. (LLY) Tops Q3 EPS by 7c; Offers FY22 EPS Guidance

Oct 18, 2022 06:58 AM Eli Lilly & Co. (LLY) Acquires Akouos (AKUS) for $610M

Aug 4, 2022 06:27 AM Eli Lilly & Co. (LLY) Misses Q2 EPS by 46c, Revenue Misses

Apr 28, 2022 06:30 AM Eli Lilly & Co. (LLY) Tops Q1 EPS by 49c, Updates Guidance

Feb 3, 2022 06:26 AM Eli Lilly & Co. (LLY) Tops Q4 EPS by 34c, Revenue Beats, Offers Guidance

Oct 26, 2021 06:26 AM Eli Lilly & Co. (LLY) Misses Q3 EPS by 2c

Aug 3, 2021 06:27 AM Eli Lilly & Co. (LLY) Misses Q2 EPS by 5c, Revenue Beats, Offers FY Guidance

Apr 27, 2021 06:28 AM Eli Lilly & Co. (LLY) Misses Q1 EPS by 27c, Lowers FY EPS Guidance

Jan 29, 2021 06:22 AM Eli Lilly & Co. (LLY) Tops Q4 EPS by 39c, Revenues Beat; Offers FY21 EPS/Revenue Guidance

Oct 27, 2020 06:36 AM Eli Lilly & Co. (LLY) Misses Q3 EPS by 17c

Jul 30, 2020 06:27 AM Eli Lilly & Co. (LLY) Tops Q2 EPS by 33c, Raises FY EPS Guidance

Apr 23, 2020 06:27 AM Eli Lilly & Co. (LLY) Tops Q1 EPS by 27c, Offers FY Guidance

Jan 30, 2020 06:28 AM Eli Lilly & Co. (LLY) Tops Q4 EPS by 21c, Updates FY Guidance

Oct 23, 2019 06:27 AM Eli Lilly & Co. (LLY) Tops Q3 EPS by 8c, Updates Guidance

Jul 30, 2019 06:27 AM Eli Lilly & Co. (LLY) Tops Q2 EPS by 5c, Revenue Beats, Updates FY Guidance

Apr 30, 2019 06:26 AM Eli Lilly & Co. (LLY) Tops Q1 EPS by 1c, Offers Guidance

Feb 6, 2019 06:27 AM Eli Lilly & Co. (LLY) Misses Q4 EPS by 1c, Revenue Beats, FY19 EPS Guidance Misses

Jan 7, 2019 06:31 AM Lilly (LLY) to Acquire Loxo Oncology (LOXO) in $8 Billion Deal

Nov 6, 2018 06:28 AM Eli Lilly & Co. (LLY) Tops Q3 EPS by 4c, Raises FY EPS Guidance

Jul 24, 2018 06:26 AM Lilly (LLY) Tops Q2 EPS by 20c

Jul 24, 2018 06:21 AM Lilly (LLY) to Separate Elanco Animal Health with IPO

Apr 24, 2018 06:27 AM Eli Lilly & Co. (LLY) Tops Q1 EPS by 21c, Raises FY EPS Guidance

Jan 31, 2018 06:26 AM Eli Lilly & Co. (LLY) Tops Q4 EPS by 7c, FY Guidance Tops Views

Oct 24, 2017 06:28 AM Eli Lilly & Co. (LLY) Tops Q3 EPS by 2c; Reviewing Strategic Alternatives for Elanco Animal Health

Jul 25, 2017 06:26 AM Eli Lilly & Co. (LLY) Tops Q2 EPS by 6c; Raises Outlook

Apr 25, 2017 06:27 AM Eli Lilly & Co. (LLY) Tops Q1 EPS by 2c

Apr 14, 2017 10:05 AM Eli Lilly (LLY), Incyte (INCY) Announce FDA CRL for RA Treatment Baricitinib

Jan 31, 2017 06:26 AM Eli Lilly & Co. (LLY) Misses Q4 EPS by 2c, Sales Beat

Jan 18, 2017 06:47 AM Eli Lilly (LLY) to Acquire CoLucid Pharmaceuticals (CLCD) for $960M

Dec 15, 2016 06:27 AM Eli Lilly & Co. (LLY) Sees FY17 Adj. EPS of $4.05-$4.15, Versus $3.97 Consensus

Nov 23, 2016 06:45 AM Eli Lilly & Co. (LLY) Announces Solanezumab Phase 3 in Alzheimer's Disease Missed Primary Endpoint

Oct 25, 2016 06:26 AM Eli Lilly & Co. (LLY) Misses Q3 EPS by 7c

Jul 27, 2016 06:47 AM Eli Lilly & Co. (LLY) Chairman, CEO Lechleiter to Retire; Successor Named

Jul 26, 2016 06:27 AM Eli Lilly & Co. (LLY) Reports In-Line Q2 EPS; Offers Longer-Term Guidance Update

Apr 26, 2016 06:25 AM Eli Lilly & Co. (LLY) Misses Q1 EPS by 2c

Jan 28, 2016 06:26 AM Eli Lilly & Co. (LLY) Reports In-Line Q4 EPS

Jan 5, 2016 06:47 AM Eli Lilly & Co. (LLY) Guides FY16 adj.-EPS Below Views; Updates FY15 Outlook

Oct 22, 2015 06:26 AM Eli Lilly & Co. (LLY) Tops Q3 EPS by 14c

Oct 12, 2015 08:01 AM Eli Lilly & Co. (LLY) to Terminate Evacetrapib Development; Sees Charges

Oct 12, 2015 08:01 AM Eli Lilly & Co. (LLY) to Discontinue Development of Evacetrapib

Jul 23, 2015 06:26 AM Eli Lilly & Co. (LLY) Tops Q2 EPS by 16c; Updates FY15 Outlook

Apr 23, 2015 06:26 AM Eli Lilly & Co. (LLY) Tops Q1 EPS by 11c